SO 1761(E)
Notification - The Narcotic Drugs and Psychotropic Substances Act, 1985
- Kind: Notification
- Under: The Narcotic Drugs and Psychotropic Substances Act, 1985
Text of this notification
REGD. NO. D. L.-33004199
Ztze Gazette o f J n d i a
wmml
EXTRAORDINARY
Pmr U - r n 3-m-rn (ii)
PART 11--Seetion U u b - ~ e e t i ~ n (ii)
PUBLISHED BY AUTHORITY
. 15873 @ m, -, XkZ 26, 2 0 1 8 b 6, 1940
No. 15871 NEW DELHI, THURSDAY, APRIL 26, MI(INA1SAKHA 6,1940
2 THE GAZETTE O F INDIA : EXTRAORDINARY [PART U-SEC. 3(ii)] ;' t
MINISTRY OF FINANCE
@EPARTMENT OF REVENUE)
NOTiFlCATlON
New Delhi, the 26th April. 2018
S. 0. 1761(E)-Whueas the Central Government is satisfied, on the basis of information and evidence which
has become available to it, with respect to the nature and effect of and the scope for abuse of the following substance
(naNral or synthetic) or natural material or any salt or preparation of such substances or materials, and the modification
with respect to such substances, and that it is necessary to add the following ~ubstance or natural material or salts or
preparation of such substance or material in the list of psychotropic substances spec~fied in the Schedule to the NarcMic
Drugs and Psychotropic Substances Act. 1985 (61 of 1985) (hereinafter referred to as the said Act):
Now, therefore, in exercisc of the powers conferred by scction 3 of the sud Act the Cenwl Government hereby
makes thc following further mcndmenL? in the list of ps)chwopic subslances spec~fied in the Schedule lo ihe said Act,
namely: -
In the said Act, in the Schedule, after serial number 110 X and the entries dating thereto. the following serial
number and entries shall be inserted, namely: -
[F. No. N-11012/3/2017-NC. Ul
W A Y KUMAR BALYAN, Under Secy.
Chemical name
Note: The Schedule to the Narcotic D ~ g s and Psychotropic Substances Act, 1985 (61 of 1985) was
f ! amended videnumber S.O. 785(E) dated 26" October, 1992 and subsequently amended
vide numbers S.O. 49(E), dated the 8Ih January, 1993, S.O. 39(E), dated the 12" January,
1996, S.O. 4 7 5 0 , dated the illh June, 2003, G.S.R. 621(E), dated the 1" August, 2003,
G.S.R. l(E), dated the znd January, 2004, S. 0. 311 Q, dated the lom February, 2011, S. 0.
376 Q, dated the 5" February, 2015, S. 0. No. 2374 (E), dated the 12& July, 2016, S.O. NO.
1383 (E), dated the znd May, 2017 and S.O. No. 821(E), dated the 27" February, 2018.
Other SI. No.
non-proprietary names
International
non-proprietary names
"llOY 1 Tramadol 1 I
- - 4 THE G A z ! 3 m OF IM)IA : EXTRAORDINARY [PART l l - 4 ~ ~ . 3(ii)l
[F. NO. N-11012/3/2017-NC. JIJ
W A Y KUMAR BALYAN, Under Secy.
Note.: The principal notification was published in the Gazette of inha, Exrnmdinary, Pait II. Section 3. Sub-section (ii).
vide number S.O. 1055 (E), dated the 19' October, 2001 and subsequently amended vide numbers S.O. 2941 (El.
dated the 18'" November, 2699, S.O. 1430 a), dated !he 21" June, 201 l.S.O. 375 (E) dated the 5Ih February,
2015,S.0.2375(E), dated the 12'July, 2016, S.O. 384 (E), dated the 2" May, 2017 and S.O. 822 (E), dated the
2 p February, 2018.
C o m m d
QunntiW
(In gmJ kg.)
6
2.50 p"
RAKESH zzM
LbternIW37 SUKUL ass,,,
SmPuQlunaty
(in w.)
5
5 gm
S No.
1
"238 ZH
UC"-dd by Me. of h t i w at Oovernmenl of India h. Ring Road Mayapuri. New klhi-llM)64
Md Published by tbs ConfR,uiW of PublicaaWw. Delhi-llIm54.
Name at Narcotic D n q
and Psychotropic
Subwnoee
(International non-
prepriehuy m e (INN))
2
TW~OI
C M h nm-
proprteuvy name
3
Cbemiul
Name
4
riir.al. 17a2(X).- @ W T : M VTRf m, 1985 (1985 3T 61) iff pmr 2 %
mviiiii) 3hC (xxiiii) % $; rn &+d w Vil w3 g, k m, yaza-cr, pma m, i3-s
m, ~ i % P T i f f ~ ~ i t ; r . ~ r r . 1055 ( a r ) , M 19 w, 2001, % f ; k m W T ? r % f i ,
~mr~mor%m, l l r - 3 , m ( i i ) i f ~ h m m , i f ~ ~ d $ , ~ : -
~&r-*&if, me. 2 3 8 2 ~ 3 h C ? i d i G 4 ' f k & f & ? i % f i ~ ~ i m ? h & 3 &
rnM****m, *:-
NOTIFICATION
New Delhi, the 26th April, 2018
S. 0. 1762(E).-In exercise of the powers conferred by clauses (viia) and (xxiiia) of section 2 of Ihe Narcotic
Drugs and Psychotropic Substances Act, 1985 (61 of 1985). the Central Government hereby makes the following further
amendments in the notification of the Government of hdia, Ministry of hnance. D e p m e n t of Revenue, p;!Lshed in
the Gazette of India. Extraordinary, Part U, Section 3, Sub-section (u) vide number S.O. I055 (E), dated the 19 October.
2001, namely: -
I,, the ssid notjticarion, in the nbie , aftcr serial numkr 238 ZG and the enuies relating (hento, the following
s e d number and entries shall be inserted, namely: -
('& . -
I INDIAN DRUG MANU URERS ASSOClATlON B-41115 (2* floor), Safdarjung Enclave, New Delh~ 110 028
-
Phone 91-11 - 26171367 E mall ~drnadelh~@gml corn
91-11 - 41650726 skmadan idma@gma~l w m
Fax 91-11 -26171369 Webs~te w ~dmb-assn wg
INDIAN PHARMACEUTICALS FOR GLOBAL HEALTH
M a y 02,2018
Mr. Dinesh Boudk
Deputy Secretaiy (Narcotics Control),
Department of Revenue,
Ministry of Finance, t
North Block, New DeIhi - 110001
Subject: Notification of Tramadol as a Psychotropic substance - S. 0. 1761(E) -
regarding.
Dear Sir,
Greetings fmm Indian Drug Manufachuem' Association
The Government of India has issued a notification dated April 26th 2018 - S. 0.
1761(E), classifying "Tramadol" and it's preparations as a Psychotropic substance and
bringing it under the purview of the NDPS Act, 1985 and Rules, thereunder.
Tramadol is an effective pain killer and prescribed extensively by medical practitioners,
across the country. Bringing them under the NDPS Act, 1985 without providing
reasonable time for Companies manufacturing and exporting Tramadol APIs and
preparations, would result in instant violation of the NDPS Act, 1985 resulting in
saious implications for Companies, Distributors and Retailers across the country.
For example, Companies who do not manufacture any Psychotropic substances would
need to file for new registration with Central Bureau of Narcotics, Gwalior which could
take time or there could be APIs or preparations under clearance for export which
would amount to violation, as no NOC for export has h e n obtained from CBN as per
Rule 58 and 59 or labeling of Tramadol preparations, already in the supply chain in the
domestic market may need to be redone, as labe& requirements for Psychotropic
substances under the D&C Act, 1940 need to be complied. The incorrect labeling of
Tramadol preparations in the supply chain, currently available with distributors and
retailers may be interpreted as a violation of NDPS Act due to this notification, having
Head OW: 102-0, P 0 0 ~ r n Chambers. 'A' WING, Dr. A.6 Road, Worli, Mumbai - 400 018 (Indig)
Ph.: 022 - 24944624, 24974308 Fax: 022 - 24950723 E mail: idmal@idrnaindia.com
Registered under the Societies Reg. Act XXI of 1860 Reg. No. Bom. 11111961 G.B.B.S.D.
Registered under the Bornhay PuMi TmMAq 18W (Eom. XXlX of 1950) Reg. No. F-1514 (Bom.) Dt. 13-4-67
immediate effect. This in turn would lead to a panic situation leading to non-availability
of this pain killer for needy patients.
It is our humble submissio;~ that a period of 6 months need to be provided for
Companies to comply with provisions of NDPS Rule 65, 67 58 or 59 and the D&C Act
with regards to labeling. This time period is requimd to sensitize all stakeholders about
this notification and would also enable the current inventory in the supply chain to be
exhausted. We wish to draw your kind notice to the fact, that when RCS Or& was
amended in 2013 and also when NDPS amendment was done in May 2015, a period of 6
months was given for ensuring proper compliance with the amended order / rulm.
We therefore, request that Rule 65 may be amended to indude a proviso, stating "Any
new substance which iws an establislted medical or suentific use and included in the list of
Psydwtropic substnnces specified in tlte schedule to the Act amM come into e@ct on fhe 180th
dnyfmm fke &te of suclz notificahon".
We request your kind consideration and an URGENT amendment to the Rules or an
appropriate clarification prwiding time for necessary compliance.
With best regards,
Yours Sincerely,
Deepnath Roy Qlowdhury
National President
All of The Narcotic Drugs and Psychotropic Substances Act, 1985